A new class of nanoparticles that accumulate inside tumors could one day improve imaging quality and cancer treatment by delivering image-enhancing agents or cancer drugs directly to tumor sites. A team led by Erkki Ruoslahti, a professor at the Burnham Institute for Medical Research in La Jolla, CA, coated iron oxide nanoparticles with a peptide that is attracted to protein clots in tumor blood vessels. When injected into mice with breast cancer, the nanoparticles sought out the tumors and bound to their blood-vessel walls. For reasons the researchers do not yet understand, the particles also induced more clotting, which attracted more particles, enhancing their effectiveness and potentially choking off a tumor’s lifeblood. The team is working to ensure that the particles won’t build up in normal tissues.
Forget dating apps: Here’s how the net’s newest matchmakers help you find love
Fed up with apps, people looking for romance are finding inspiration on Twitter, TikTok—and even email newsletters.
How AI could solve supply chain shortages and save Christmas
Just-in-time shipping is dead. Long live supply chains stress-tested with AI digital twins.
These weird virtual creatures evolve their bodies to solve problems
They show how intelligence and body plans are closely linked—and could unlock AI for robots.
How AI is reinventing what computers are
Three key ways artificial intelligence is changing what it means to compute.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.